SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about newspaper publication

17 Nov 2018 Evaluate

Anuh Pharma has informed about submission of copies of newspaper advertisement with respect to the Unaudited Financial Results for the quarter & half year ended 30th September, 2018, published in the Free Press Journal and in Navshakti on Thursday, 15th November, 2018 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company's filings submitted to BSE.

Anuh Pharma Share Price

78.36 -0.23 (-0.29%)
25-Jun-2026 10:13 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1879.40
Dr. Reddys Labs. 1356.70
Cipla 1441.55
Zydus Lifesciences 1101.90
Lupin 2366.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: